IL162850A0 - Nitric oxide donors for treatment of disease and injury - Google Patents
Nitric oxide donors for treatment of disease and injuryInfo
- Publication number
- IL162850A0 IL162850A0 IL16285003A IL16285003A IL162850A0 IL 162850 A0 IL162850 A0 IL 162850A0 IL 16285003 A IL16285003 A IL 16285003A IL 16285003 A IL16285003 A IL 16285003A IL 162850 A0 IL162850 A0 IL 162850A0
- Authority
- IL
- Israel
- Prior art keywords
- injury
- disease
- treatment
- nitric oxide
- oxide donors
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical class O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 1
- 208000027418 Wounds and injury Diseases 0.000 title 1
- 230000006378 damage Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000014674 injury Diseases 0.000 title 1
- 239000002840 nitric oxide donor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34547802P | 2002-01-04 | 2002-01-04 | |
| PCT/US2003/000323 WO2003056899A2 (en) | 2002-01-04 | 2003-01-06 | Nitric oxide donors for treatment of disease and injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162850A0 true IL162850A0 (en) | 2005-11-20 |
Family
ID=23355218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16285003A IL162850A0 (en) | 2002-01-04 | 2003-01-06 | Nitric oxide donors for treatment of disease and injury |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20050143388A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1469852A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4545440B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1638775A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003210447B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2471147C (cg-RX-API-DMAC7.html) |
| IL (1) | IL162850A0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003056899A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200405507B (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1909793A2 (de) * | 2005-07-15 | 2008-04-16 | Proxomed Medizintechnik GmbH | Verwendung von phosphodiesterase typ 5-hemmern für die prävention und behandlung von erkrankungen oder gesundheitsstörungen, sowie abgabesysteme für dieselben |
| CA2629463A1 (en) * | 2005-11-14 | 2008-02-21 | Scott A. Small | Imaging correlates of neurogenesis with mri |
| US8841300B2 (en) | 2006-10-02 | 2014-09-23 | Jerry M. Held | Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor |
| WO2008144061A2 (en) * | 2007-05-18 | 2008-11-27 | Vivus, Inc. | Novel combinations comprising a phosphodiesterase-5 inhibitor and their use |
| WO2009046377A2 (en) * | 2007-10-04 | 2009-04-09 | Medistem Laboratories, Inc. | Compositions and methods of stem cell therapy for autism |
| WO2009059271A1 (en) * | 2007-11-02 | 2009-05-07 | University Of Miami | Diagnosis and treatment of cardiac disorders |
| US9469637B2 (en) | 2012-04-25 | 2016-10-18 | Takeda Pharmaceutical Company Limited | Nitrogenated heterocyclic compound |
| WO2014010732A1 (ja) | 2012-07-13 | 2014-01-16 | 武田薬品工業株式会社 | 複素環化合物 |
| DK2961741T3 (en) * | 2013-03-01 | 2017-07-03 | Fund Para La Investig Medica Aplicada | Novel compounds as dual inhibitors of phosphodiesterases and histone deacetylases |
| US9834520B2 (en) | 2013-03-14 | 2017-12-05 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| WO2015002231A1 (ja) | 2013-07-03 | 2015-01-08 | 武田薬品工業株式会社 | 複素環化合物 |
| ES2950424T3 (es) | 2013-07-03 | 2023-10-09 | Takeda Pharmaceuticals Co | Compuesto de amida |
| US10297661B2 (en) * | 2017-06-30 | 2019-05-21 | Taiwan Semiconductor Manufacturing Co., Ltd. | High voltage resistor device |
| TWI879058B (zh) * | 2023-08-31 | 2025-04-01 | 未來新藥股份有限公司 | Pde5抑制劑組合於促進神經突生長之新穎用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2187086A1 (en) * | 1994-04-15 | 1995-10-26 | Masaomi Iyo | A pharmaceutical composition for therapeutically treating tardive dyskinesia and uses therof |
| US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
| US6043224A (en) * | 1996-09-05 | 2000-03-28 | The Massachusetts Institute Of Technology | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| US6043223A (en) * | 1997-11-12 | 2000-03-28 | The Regents Of The University Of California | Enhanced opening of abnormal brain tissue capillaries |
| DE19834507A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil |
| CA2373808C (en) * | 1999-05-14 | 2011-04-19 | Henry Ford Health System | Bone marrow transplantation for treatment of central nervous system damage |
| ATE408402T1 (de) * | 1999-06-14 | 2008-10-15 | Ford Henry Health System | Stickstoffmonoxid-donoren zum induzieren von neurogenese |
| US6075028A (en) * | 1999-09-23 | 2000-06-13 | Graham; Richard | Method of treating Tourette's syndrome and related CNS disorders |
| IL139073A0 (en) * | 1999-10-21 | 2001-11-25 | Pfizer | Treatment of neuropathy |
| US6271228B1 (en) | 2000-04-28 | 2001-08-07 | Pfizer Inc. | Blood pressure stabilization during hemodialysis |
| EP1355669B1 (en) * | 2000-08-10 | 2011-09-28 | Cold Spring Harbor Laboratory | Augmented cognitive training |
-
2003
- 2003-01-06 JP JP2003557275A patent/JP4545440B2/ja not_active Expired - Fee Related
- 2003-01-06 WO PCT/US2003/000323 patent/WO2003056899A2/en not_active Ceased
- 2003-01-06 CA CA2471147A patent/CA2471147C/en not_active Expired - Fee Related
- 2003-01-06 CN CNA038048817A patent/CN1638775A/zh active Pending
- 2003-01-06 US US10/500,694 patent/US20050143388A1/en not_active Abandoned
- 2003-01-06 IL IL16285003A patent/IL162850A0/xx unknown
- 2003-01-06 AU AU2003210447A patent/AU2003210447B2/en not_active Ceased
- 2003-01-06 EP EP03729347A patent/EP1469852A4/en not_active Withdrawn
-
2004
- 2004-07-12 ZA ZA2004/05507A patent/ZA200405507B/en unknown
-
2009
- 2009-08-04 JP JP2009181759A patent/JP2009256374A/ja active Pending
-
2010
- 2010-09-24 US US12/889,873 patent/US20120009152A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP4545440B2 (ja) | 2010-09-15 |
| CN1638775A (zh) | 2005-07-13 |
| CA2471147A1 (en) | 2003-07-17 |
| AU2003210447B2 (en) | 2008-02-07 |
| WO2003056899A2 (en) | 2003-07-17 |
| US20050143388A1 (en) | 2005-06-30 |
| JP2009256374A (ja) | 2009-11-05 |
| WO2003056899A9 (en) | 2004-04-15 |
| EP1469852A4 (en) | 2009-12-02 |
| CA2471147C (en) | 2010-08-10 |
| US20120009152A1 (en) | 2012-01-12 |
| ZA200405507B (en) | 2005-05-25 |
| AU2003210447A1 (en) | 2003-07-24 |
| EP1469852A2 (en) | 2004-10-27 |
| JP2005514406A (ja) | 2005-05-19 |
| WO2003056899A3 (en) | 2003-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003290548A8 (en) | Prevention and treatment of synucleinopathic disease | |
| AU2002303295B2 (en) | Diagnosis and treatment of neural disease and injury using microvoltammetry | |
| AU2003246102A8 (en) | Method of examining allergic disease and drug for treating the same | |
| EP1551399A4 (en) | METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT | |
| AU2003300939A8 (en) | Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same | |
| GB0612417D0 (en) | Compositions and methods for topical treatment of skin infection | |
| AU2003256253A8 (en) | Aerosol for medical treatment and methods | |
| EP1641378A4 (en) | METHOD AND DEVICES FOR TREATING SKIN Lions | |
| AU2003278775A8 (en) | Porifera-based therapeutic compositions for treating and preventing skin diseases | |
| ZA200505272B (en) | Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines | |
| AU2003265225A8 (en) | Preparations for topical skin use and treatment | |
| SI1487541T1 (sl) | Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja | |
| AU2003220096A8 (en) | Methods for alzheimer's disease treatment and cognitive enhancement | |
| AU2003268531A8 (en) | Materials and methods for treatment of allergic diseases | |
| DE60330693D1 (de) | WuRMEBEHANDLUNGSVERFAHREN UND WuRMEBEHANDLUNGSVORRICHTUNG | |
| IL162850A0 (en) | Nitric oxide donors for treatment of disease and injury | |
| EP1651255A4 (en) | TOPICAL VETERINARY COMPOSITIONS AND METHODS OF TREATING AND PREVENTING INFECTIONS | |
| EP1404281A4 (en) | TOPICAL USE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN AND / OR MUCOSAL LESIONS, USE OF COMPOSITIONS AND COMPOUNDS IN THE TREATMENT OF SKIN AND / OR MUCOUS DISEASES | |
| AU2003268295A8 (en) | "diagnosis and treatment of infertility" | |
| IL157593A0 (en) | Carbamate compounds for use in the treatment of pain | |
| HRP20030609A2 (en) | Use of il-18 inhibitors for the treatment and/or prevention of heart disease | |
| AU2003244132A8 (en) | Method of examining allergic disaese and drug for treating the same | |
| IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
| EP1569723A4 (en) | NUCLEOTIDE BASED MEDICAMENT AND METHOD FOR THEIR USE FOR THE TREATMENT OF DISEASES OF DISEASES | |
| PL377110A1 (pl) | Zapobieganie i leczenie choroby Alzheimera |